Prognostic impact of subclinical or manifest extracoronary artery diseases after acute myocardial infarction
Open Access
- 26 May 2017
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 263, 53-59
- https://doi.org/10.1016/j.atherosclerosis.2017.05.027
Abstract
No abstract availableKeywords
Funding Information
- Sveriges Läkarförbund
This publication has 28 references indexed in Scilit:
- Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromesAtherosclerosis, 2015
- Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2014
- Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: An observation from the CREDO-Kyoto Registry Cohort-2Atherosclerosis, 2013
- Polyvascular Disease and Long-Term Cardiovascular Outcomes in Older Patients With Non–ST-Segment–Elevation Myocardial InfarctionCirculation: Cardiovascular Quality and Outcomes, 2012
- An International Model to Predict Recurrent Cardiovascular DiseaseThe American Journal of Medicine, 2012
- Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance projectArchives of Cardiovascular Diseases, 2010
- Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromesEuropean Heart Journal, 2009
- Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)American Heart Journal, 2006
- Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventionsThe American Journal of Cardiology, 2004
- Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyAmerican Heart Journal, 2003